Merck & Co. revenue from United States
U.S. Revenue of Merck & Co. 2008-2021
Amounts are in $millions.
| Year | U.S. Revenue ($mn) |
| 2021 | $22,425 |
| 2020 | $19,588 |
| 2019 | $18,420 |
| 2018 | $ 18,212 |
| 2017 | $ 17,424 |
| 2016 | $ 18,478 |
| 2015 | $ 17,519 |
| 2014 | $ 17,071 |
| 2013 | $ 18,246 |
| 2012 | $ 20,392 |
| 2011 | $ 20,495 |
| 2010 | $ 20,226 |
| 2009 | $ 14,401 |
| 2008 | $ 13,371 |
2021: The largest individual market of Merck & Co is the United States which accounted for around 46% of the company's net sales in 2021 compared to around 47% in 2020. The US net revenues of the company were $22.425 billion in 2021 compared to $19.6 billion in 2020 or annual growth of 14%. The net sales of the company from the international markets grew by around 20% in 2021 compared to the previous year. Its total net sales in the international market was $26.28 billion in 2021 compared to $21.9 billion in 2020.
2018: The United States is the leading market of Merck & Co. which accounted for more than 40% of its revenue in 2018. Revenue of Merck & Co. from the United States market was $18.2 billion in 2018 compared to $17.42 billion in 2017.